A field service engineer (fse) went to the customer site to evaluate the problem.The fse performed pm.During pm, the fse replaced the syringe tip and lubricated the syringe assembly.After pm was completed, error code 707 recurred during shutdown.The fse replaced the sys motor and ran eleven (11) patients to test operation; however, error 707 persisted after run was completed and switched to stand-by.The fse returned on 27-sep-2016 to replace the drv2 board.Following the fse ran qcs and patients samples without error.The fse verified operation of the g8 analyzer and it was ready for use.The most probable cause of the reported problem is related to failure of the drv2 board.The g8 service, operator's, and training manuals were reviewed and found to clearly address calibration, quality controls, operation, maintenance, error codes, and troubleshooting pertaining to the g8 system.The g8 operator's manual informs the user of the following: error message: 707 syringe-s error.Explanation: operation error in syringe-s.Countermeasure: inspect syringe-s.Execute smp.Reset.707 syringe-s error: content: operation error in syringe-s.Monitoring method: unexpected home sensor and limiter sensors signals are monitored.During syringe s operation (refer to error log in "4.10 how to read the log").Causes: a) incorrect syringe s operation b) sys motor fault c) sys-u sensor fault d) sys-d sensor fault e) drv2 board fault f) asm board fault.Countermeasures: a) inspect syringe s b) inspect the sys motor c) inspect sensors d) inspect boards.(b)(4).This report is being submitted due to a retrospective review conducted under capa-(b)(4).
|
On (b)(6) 2016, the customer called tosoh technical support (tts) to report receiving error code 707 (small syringe errors) during use of the g8 analyzer.The customer requested a field service engineer (fse) come on-site to perform preventive maintenance (pm) on the g8 analyzer.A field service engineer (fse) was dispatched to address the reported event, which resulted in delayed reporting of patient results for hba1c.There was no indication of patient intervention or adverse health consequences due to the delay in reporting.
|